GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Novo Integrated Sciences Inc (NAS:NVOS) » Definitions » Beneish M-Score

Novo Integrated Sciences (Novo Integrated Sciences) Beneish M-Score : -2.52 (As of May. 11, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Novo Integrated Sciences Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.52 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Novo Integrated Sciences's Beneish M-Score or its related term are showing as below:

NVOS' s Beneish M-Score Range Over the Past 10 Years
Min: -5.64   Med: -2.69   Max: -0.96
Current: -2.52

During the past 13 years, the highest Beneish M-Score of Novo Integrated Sciences was -0.96. The lowest was -5.64. And the median was -2.69.


Novo Integrated Sciences Beneish M-Score Historical Data

The historical data trend for Novo Integrated Sciences's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Integrated Sciences Beneish M-Score Chart

Novo Integrated Sciences Annual Data
Trend Dec14 Dec15 Dec16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.13 -3.04 -2.80 -4.41 -3.41

Novo Integrated Sciences Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.84 -5.64 -3.41 -2.15 -2.52

Competitive Comparison of Novo Integrated Sciences's Beneish M-Score

For the Medical Care Facilities subindustry, Novo Integrated Sciences's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Integrated Sciences's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Novo Integrated Sciences's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Novo Integrated Sciences's Beneish M-Score falls into.



Novo Integrated Sciences Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Novo Integrated Sciences for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.9941+0.528 * 1.0668+0.404 * 0.9609+0.892 * 1.169+0.115 * 1.0641
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8404+4.679 * -0.21394-0.327 * 1.4969
=-2.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Feb24) TTM:Last Year (Feb23) TTM:
Total Receivables was $2.15 Mil.
Revenue was 3.171 + 3.891 + 3.303 + 3.293 = $13.66 Mil.
Gross Profit was 1.324 + 1.944 + 0.928 + 1.314 = $5.51 Mil.
Total Current Assets was $5.02 Mil.
Total Assets was $34.95 Mil.
Property, Plant and Equipment(Net PPE) was $7.16 Mil.
Depreciation, Depletion and Amortization(DDA) was $2.30 Mil.
Selling, General, & Admin. Expense(SGA) was $14.89 Mil.
Total Current Liabilities was $9.96 Mil.
Long-Term Debt & Capital Lease Obligation was $1.70 Mil.
Net Income was -2.746 + -4.68 + -3.16 + -1.497 = $-12.08 Mil.
Non Operating Income was 0.045 + -0.126 + 0.38 + 0.048 = $0.35 Mil.
Cash Flow from Operations was -1.714 + -2.152 + -0.229 + -0.858 = $-4.95 Mil.
Total Receivables was $0.92 Mil.
Revenue was 2.557 + 3.419 + -8.145 + 13.852 = $11.68 Mil.
Gross Profit was 0.971 + 1.74 + -0.092 + 2.409 = $5.03 Mil.
Total Current Assets was $4.05 Mil.
Total Assets was $36.49 Mil.
Property, Plant and Equipment(Net PPE) was $7.70 Mil.
Depreciation, Depletion and Amortization(DDA) was $2.69 Mil.
Selling, General, & Admin. Expense(SGA) was $15.16 Mil.
Total Current Liabilities was $6.18 Mil.
Long-Term Debt & Capital Lease Obligation was $1.96 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2.154 / 13.658) / (0.924 / 11.683)
=0.15771 / 0.079089
=1.9941

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(5.028 / 11.683) / (5.51 / 13.658)
=0.430369 / 0.403427
=1.0668

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5.019 + 7.163) / 34.949) / (1 - (4.051 + 7.7) / 36.489)
=0.651435 / 0.677958
=0.9609

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=13.658 / 11.683
=1.169

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2.691 / (2.691 + 7.7)) / (2.304 / (2.304 + 7.163))
=0.258974 / 0.243372
=1.0641

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(14.893 / 13.658) / (15.158 / 11.683)
=1.090423 / 1.297441
=0.8404

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1.703 + 9.959) / 34.949) / ((1.956 + 6.178) / 36.489)
=0.333686 / 0.222916
=1.4969

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-12.083 - 0.347 - -4.953) / 34.949
=-0.21394

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Novo Integrated Sciences has a M-score of -2.52 suggests that the company is unlikely to be a manipulator.


Novo Integrated Sciences Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Novo Integrated Sciences's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Novo Integrated Sciences (Novo Integrated Sciences) Business Description

Traded in Other Exchanges
N/A
Address
11120 NE 2nd Street, Suite 100, Bellevue, WA, USA, 98004
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.
Executives
Sarfaraz Ali director C/O NOVO INTEGRATED SCIENCES, INC.,, 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Robert Letterio Oliva director 115 BELFIELD RD, TORONTO A6 L0J 1C0
Sterling M. Jimenez officer: Principal Financial Officer C/O NOVO INTEGRATED SCIENCES, INC.,, 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Michael Ross Pope director 1045 PROGRESS CIRCLE, LAWRENCEVILLE, GEORGIA GA 30043
Alex Flesias director 41 LANDMARK COURT, UNIONVILLE A6 L3R 9N7
Michael Joseph Gaynor director 49 BALMORAL ST, KEMPTVILLE A6 K0G 1J0
Robert Mattacchione director, 10 percent owner, officer: Chief Executive Officer 79 SELVAPIANO CRES, WOODBRIDGE A6 L4H 0X1
Pierre Joseph Dalcourt director, 10 percent owner 35 BRYANT ST , BOX 2230, HEARST A6 P0L 1N0
Christopher Mehlin David director, officer: President 10425 SE 22ND ST., BELLEVUE WA 98004
Thomas Edward Bray officer: Principal Financial Officer C/O NOVO INTEGRATED SCIENCES, INC., 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Rebecca Aw Mcdonald officer: Chief Accounting Officer 1301 INTERNATIONAL SPEEDWAY BLVD., DELAND FL 32724
James Jr Teters director 1200 FLIGHTLINE BLVD, STE 5, DELAN FL 32724
Phyllis Rouse officer: secretary 1200 FLIGHLINE BLVD,, SUITE 5, DELAND FL 32724
Jay Hilden officer: President & CEO 1200 FLIGHLINE BLVD,, SUITE 5, DELAND FL 32724
Robert Adamo director 1200 FLIGHTLINE BOULEVARD, SUITE 5, DELAND FL 32724